Surrozen Inc./$SRZN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Ticker
$SRZN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
41
ISIN
US86889P2083
Website
Surrozen Inc. Metrics
BasicAdvanced
$73M
-
-$24.62
-
-
Price and volume
Market cap
$73M
52-week high
$14.00
52-week low
$5.90
Average daily volume
11K
Financial strength
Current ratio
10.018
Quick ratio
9.854
Long term debt to equity
119.457
Total debt to equity
140.43
Management effectiveness
Return on assets (TTM)
-21.41%
Return on equity (TTM)
-456.32%
Valuation
Price to revenue (TTM)
2.464
Price to book
12.94
Price to tangible book (TTM)
12.94
Price to free cash flow (TTM)
-1.575
Growth
Earnings per share change (TTM)
33.58%
3-year earnings per share growth (CAGR)
-1.50%
Surrozen Inc. News
AllArticlesVideos
Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
GlobeNewsWire·3 weeks ago
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewsWire·4 weeks ago
Insiders Are Loving These 5 Tech and Biotech Stocks
24/7 Wall Street·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Surrozen Inc. stock?
Surrozen Inc. (SRZN) has a market cap of $73M as of June 06, 2025.
What is the P/E ratio for Surrozen Inc. stock?
The price to earnings (P/E) ratio for Surrozen Inc. (SRZN) stock is 0 as of June 06, 2025.
Does Surrozen Inc. stock pay dividends?
No, Surrozen Inc. (SRZN) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next Surrozen Inc. dividend payment date?
Surrozen Inc. (SRZN) stock does not pay dividends to its shareholders.
What is the beta indicator for Surrozen Inc.?
Surrozen Inc. (SRZN) does not currently have a Beta indicator.